11/17/20 7:30 AMNasdaq : JAZZJazz Pharmaceuticals Appoints Jennifer Cook and Mark Smith, M.D. to its Board of DirectorsJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jennifer Cook and Mark D. Smith, M.D. have been appointed to the Company's Board of Directors, effective December 1, 2020."We are excited to welcome two industry leaders to the Board whoseRHEA-AIvery positive
11/10/20 4:05 PMNasdaq : JAZZJazz Pharmaceuticals Announces Participation at Jefferies Virtual London Healthcare ConferenceJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the following virtual healthcare conference:Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020 at 1:10 p.m. EST / 6:10RHEA-AIneutral
11/05/20 7:30 AMNasdaq : JAZZData at ASH 2020 Annual Meeting Highlights Jazz Pharmaceuticals' Commitment to Advancing Hematology/Oncology ResearchJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 11 company-sponsored abstracts, in addition to two abstracts from collaboration trials with The University of Texas MD Anderson Cancer Center (MD Anderson), one abstract from a cooperative group trialRHEA-AIneutral
11/02/20 4:05 PMNasdaq : JAZZJazz Pharmaceuticals Announces Third Quarter 2020 Financial ResultsJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2020 and updated its 2020 financial guidance. "We delivered strong financial results this quarter, with increasingly diversified revenues fueled by the recentRHEA-AIvery positive
10/26/20 7:30 AMNasdaq : JAZZ, SWTXJazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor ProgramJazz Pharmaceuticals plc (Nasdaq: JAZZ) and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) ("SpringWorks") today announced that Jazz Pharmaceuticals Ireland Limited ("Jazz") and SpringWorks have entered into an asset purchase and exclusiveRHEA-AIneutral
10/20/20 7:30 AMNasdaq : JAZZJazz Pharmaceuticals Announces SLEEP Publication of Phase 3 Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Study in Cataplexy or Excessive Daytime Sleepiness in Patients with NarcolepsyJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the publication of the global Phase 3 double-blind, placebo-controlled, randomized-withdrawal, multicenter study of Xywav(TM) (calcium, magnesium, potassium and sodium oxybates) oral solution, for theRHEA-AIneutral
10/19/20 4:15 PMNasdaq : JAZZJazz Pharmaceuticals Announces Webcast for Xywav Investor UpdateJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Monday, October 26, 2020 at 4:30 p.m. EDT / 8:30 p.m. GMT to provide investors with an update on Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) oralRHEA-AIneutral
10/19/20 4:05 PMNasdaq : JAZZJazz Pharmaceuticals to Report 2020 Third Quarter Financial Results on November 2, 2020Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 third quarter financial results on Monday, November 2, 2020, after the close of the financial markets. Company management will host a live audio webcast immediately followingRHEA-AIneutral
10/14/20 4:05 PMNasdaq : JAZZNew Data for Zepzelca(TM) (lurbinectedin) to be Presented at IASLC 2020 North America Conference on Lung CancerJazz Pharmaceuticals plc (Nasdaq: JAZZ) and its partner PharmaMar (MSE: PHM) today announced they will present new data for Zepzelca(TM) (lurbinectedin) in small cell lung cancer (SCLC) at the International Association for the Study of Lung Cancer (IASLC) 2020RHEA-AIvery positive
10/08/20 7:30 AMNasdaq : JAZZJazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic HypersomniaJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive top-line results from the Phase 3 double-blind, multicenter, placebo-controlled, randomized withdrawal study evaluating the efficacy and safety of an investigational use of Xywav(TM) (calcium,RHEA-AIneutral
